Please note: This post is for informational purposes only. As of 2014, Simmons Hanly Conroy is no longer accepting cases involving Yaz.
Yaz is a birth-control pill that prevents ovulation and makes it harder for sperm to reach the uterus and for a fertilized egg to attach to the uterus. Yaz and Yasmin use a new progestin—drospirenone—that distinguishes them from other birth control pills. Two studies on drospirenone by independent researchers have found a slight increase in blood clots, while one study sponsored by Bayer found no increased risk in blood clots.
According to a lawsuit filed in July 2009, more than 50 reports of death for Yaz/Yasmin users occurred from 2004-2008. Bayer, the manufacturer of Yaz, says that it has been served with 74 Yaz lawsuits from women who claim they have experienced dangerous side effects as a result of taking the best-selling birth control pill in the United States.
The FDA’s Warning to Bayer
Bayer, the manufacturer of Yaz, was the subject of an FDA warning that asserted:
- Television ads are “false and misleading”.
- Ads overstate the drug’s efficacy.
- Ads minimize the serious risks associated with the drug.
- Ads promoted the drug’s use for PMS, for which it is not approved.
- A German plant that makes its hormone ingredients did not calculate variability to American standards.
As a result, Bayer put $20 million into a corrective advertising campaign.
The Dangers of Yaz
There are many reasons women are filing Yaz lawsuits, including:
- blood clot (heart or lung)
- heart attack
- kidney failure
- cardiac arrhythmias
- pulmonary embolism
- deep vein thrombosis
- gall bladder problems, sometimes necessitating surgery
Simmons Hanly Conroy is not only dedicated to fighting for the rights of people, we are also dedicated to protecting the public against dangerous drugs. If you or a loved one has experienced one of the above side effects of Yaz, we can help with information about your legal options; although as of 2014, Simmons Hanly Conroy is no longer accepting cases involving Yaz or Yasmin.
Named shareholder Jayne Conroy was a court-appointed co-chair of Plaintiffs’ Law and Briefing Committee in Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation. Shareholder Trent Miracle was on the Plaintiffs’ Steering Committee–In Re Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation.
I am very pleased and had a wonderful experience with the firm. Would definitely use their services again.